Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 – Clinical Trial Not Allowed)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 15, 2026
Can you apply?
This grant is for institutions and researchers developing biomedical technologies. Eligible applicants include academic medical centers, research universities, hospitals, and nonprofit research organizations. Applicants must demonstrate capacity to optimize and disseminate biomedical innovations. Geographic scope is U.S.-based institutions.
The program supports research infrastructure and technology development. Funded activities include optimization of existing technologies, dissemination to end users, and training programs. Projects should address barriers to technology adoption in healthcare settings.
Applicants must be NIH-eligible institutions with appropriate research infrastructure. Strong applications show partnerships with clinical or community partners. Institutional commitment and matching support strengthen proposals.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- Jun 8, 2026 Applications open
- Apr 1, 2027 Award announced
- Apr 1, 2027 Project start
- Jan 29, 2029 Application deadline in 928 days
Program description
The NIGMS Biomedical Technology Optimization and Dissemination Centers (BTOD) program supports optimization of late-stage technologies that have demonstrated laboratory feasibility. The centers will move the technologies to the point where they can be widely used and will promote their dissemination within the biomedical research community. NIGMS intends to reissue a Notice of Funding Opportunity to continue to support the BTOD Centers program.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- R&R SF424 (R&R) form
- Project Narrative (Research Plan)
- Budget and Budget Justification
- Biographical Sketches (key personnel)
- Supporting Documents (letters of support, data)
- Facilities and Administrative Costs documentation
Program contact
- 👤 Carolina Salvador Morales, Ph.D.
- 📧 carolina.salvadormorales@nih.gov
- 📞 301-480-0779
Funding track record
Recent awards under CFDA 93.859 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$59,464,779
-
$57,271,194
-
$56,019,458
-
$54,912,096
-
$53,329,877
-
$52,858,544
-
$52,347,059
-
$52,026,661
-
$50,897,104
-
$49,349,731
Top States by Funding
- ME 4 awards $143.3M
- MS 4 awards $135.1M
- NY 5 awards $131.6M
- CA 5 awards $129.3M
- RI 4 awards $126.3M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.859). How funding has trended year over year.
| 2024 | $3,085,929,426 | |
| 2025 | $3,092,472,727 | |
| 2026 est. | $3,093,422,000 |
FAQ
Who can apply to this grant?
Academic medical centers, research universities, hospitals, and nonprofit research organizations. Your institution must be NIH-eligible with research infrastructure.
What types of projects are funded?
Technology optimization, dissemination strategies, end-user training, and implementation research. Projects should improve access to and adoption of biomedical innovations.
What is the application timeline?
Applications open September 2, 2025. Specific deadlines vary by funding mechanism. Check NIH announcement for exact due dates.
How competitive is this grant?
NIH grants are highly competitive. Success rates typically range from 10-20%. Strong preliminary data and institutional support are essential.
What is the typical funding range?
Award amounts vary based on project scope and program mechanism. Budget requests should be well-justified based on specific aims.
💡 Tips for applicants
- Develop clear partnerships with clinical sites or end-user organizations to strengthen dissemination plans.
- Use preliminary data showing your technology works and addresses a real clinical need.
- Demonstrate institutional commitment through resource allocation and leadership support.
- Build a realistic dissemination strategy with measurable adoption metrics.
- Include budget justification explaining how funds optimize and scale your technology.
⚠️ Common mistakes
Weak dissemination strategy without clear end-user partnerships. Unclear connection between technology and clinical impact or patient benefit. Unrealistic timelines for technology optimization and adoption.
Similar grants
- OPEN HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1) — National Institutes of Health
- OPEN Funding Opportunity Announcement – NIBIB Technology Development Networks — National Institutes of Health
- OPEN Laboratories to Optimize Digital Health (R01 Clinical Trial Required) — National Institutes of Health
- OPEN Focused Technology Research and Development (R01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) — National Institutes of Health